Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leila Shaza

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Opinion in Oncology|June 3, 2026
From dose to exposure? rethinking fluoropyrimidines as immune checkpoint partners in gastrointestinal cancersAlain Hendlisz, Leila Shaza, Thierry De Grez, et al.
Clinical Journal of Gastroenterology|April 9, 2021
Nonbacterial thrombotic endocarditis in a patient with gastric cancer and SARS-CoV-2 infectionQuentin Binet, Céline Goffinet, Frédérique-Estelle Etogo-Asse, et al.
Endoscopy International Open|August 8, 2018
Comparative analysis of ESD versus EMR in a large European series of non-ampullary superficial duodenal tumorsEnrique Pérez-Cuadrado-Robles, Lucille Quénéhervé, Walter Margos, et al.
Oncotarget|February 29, 2020
Prognostic value of a three-scale grading system based on combining molecular imaging with <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasiasIoannis Karfis, Gwennaëlle Marin, Hugo Levillain, et al.
Current Research in Translational Medicine|April 8, 2018
Celyad's novel CAR T-cell therapy for solid malignanciesCaroline Lonez, Alain Hendlisz, Leila Shaza, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 1, 2019
Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing StrategiesLorraine Springuel, Caroline Lonez, Bertrand Alexandre, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Opinion in Oncology|June 3, 2026
From dose to exposure? rethinking fluoropyrimidines as immune checkpoint partners in gastrointestinal cancersAlain Hendlisz, Leila Shaza, Thierry De Grez, et al.
Clinical Journal of Gastroenterology|April 9, 2021
Nonbacterial thrombotic endocarditis in a patient with gastric cancer and SARS-CoV-2 infectionQuentin Binet, Céline Goffinet, Frédérique-Estelle Etogo-Asse, et al.
Endoscopy International Open|August 8, 2018
Comparative analysis of ESD versus EMR in a large European series of non-ampullary superficial duodenal tumorsEnrique Pérez-Cuadrado-Robles, Lucille Quénéhervé, Walter Margos, et al.
Oncotarget|February 29, 2020
Prognostic value of a three-scale grading system based on combining molecular imaging with <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasiasIoannis Karfis, Gwennaëlle Marin, Hugo Levillain, et al.
Current Research in Translational Medicine|April 8, 2018
Celyad's novel CAR T-cell therapy for solid malignanciesCaroline Lonez, Alain Hendlisz, Leila Shaza, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 1, 2019
Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing StrategiesLorraine Springuel, Caroline Lonez, Bertrand Alexandre, et al.
Pageof 1